Novoteris Granted $2.8M CFFT Award for Inhaled CF Therapy
Cystic Fibrosis, News
Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) and Novoteris, LLC recently signed a $2.8 million agreement to develop an inhaled nitric oxide antimicrobial treatment for patients who suffer from cystic fibrosis (CF). CFFT, the ... Read more